These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21971162)

  • 1. Improving MMR vaccination rates: herd immunity is a realistic goal.
    Cockman P; Dawson L; Mathur R; Hull S
    BMJ; 2011 Oct; 343():d5703. PubMed ID: 21971162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument.
    Brown KF; Shanley R; Cowley NA; van Wijgerden J; Toff P; Falconer M; Ramsay M; Hudson MJ; Green J; Vincent CA; Kroll JS; Fraser G; Sevdalis N
    Vaccine; 2011 Feb; 29(8):1700-9. PubMed ID: 21185850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination coverage among children in kindergarten--United States, 2011-12 school year.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(33):647-52. PubMed ID: 22914226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timeliness of MMR vaccination and barriers to vaccination in preschool children.
    Jeong YW; Park BH; Kim KH; Han YR; Go UY; Choi WS; Kong KA; Park H
    Epidemiol Infect; 2011 Feb; 139(2):247-56. PubMed ID: 20412613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G; Rasidah N; Wan S; Cutter J
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.
    Bernsen RM; van der Wouden JC
    Pediatr Allergy Immunol; 2008 Sep; 19(6):544-51. PubMed ID: 18266826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccinations in early infancy -- results of an epidemiological cross-sectional study in Hamburg].
    Fell G; David C; Reintjes R
    Gesundheitswesen; 2005 Jan; 67(1):27-32. PubMed ID: 15672303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare workers role in keeping MMR vaccination uptake high in Europe: a review of evidence.
    Simone B; Carrillo-Santisteve P; Lopalco PL
    Euro Surveill; 2012 Jun; 17(26):. PubMed ID: 22790533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
    Marin M; Nguyen HQ; Langidrik JR; Edwards R; Briand K; Papania MJ; Seward JF; LeBaron CW
    Clin Infect Dis; 2006 Feb; 42(3):315-9. PubMed ID: 16392073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
    Cohen C; White JM; Savage EJ; Glynn JR; Choi Y; Andrews N; Brown D; Ramsay ME
    Emerg Infect Dis; 2007 Jan; 13(1):12-7. PubMed ID: 17370510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does education about local vaccination rates and the importance of herd immunity change US parents' concern about measles?
    Griffith BC; Ulrich AK; Becker AB; Nederhoff D; Koch B; Awan FA; Basta NE
    Vaccine; 2020 Nov; 38(50):8040-8048. PubMed ID: 33158593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine.
    Vesikari T; Sadzot-Delvaux C; Rentier B; Gershon A
    Pediatr Infect Dis J; 2007 Jul; 26(7):632-8. PubMed ID: 17596807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialist vaccination advice and pockets of resistance to MMR vaccination: lessons from an outbreak of measles.
    Morgan OW; Meltzer M; Muir D; Hogan H; Seng C; Hill J; Beckford J
    Commun Dis Public Health; 2003 Dec; 6(4):330-3. PubMed ID: 15067861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for measles transmission in England.
    Choi YH; Gay N; Fraser G; Ramsay M
    BMC Public Health; 2008 Sep; 8():338. PubMed ID: 18822142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.